Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
5.59
+0.07 (1.27%)
At close: May 22, 2026, 4:00 PM EDT
5.48
-0.11 (-1.97%)
After-hours: May 22, 2026, 6:38 PM EDT

Harvard Bioscience Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Harvard Bioscience stock have an average target of $6.00, which predicts a 7.33% increase from the current stock price of 5.59.

Price Target: $6.00 (+7.33%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$6.00$6.00$6.00$6.00
Change+7.33%+7.33%+7.33%+7.33%
* Price targets were last updated on Mar 16, 2026.

Analyst Ratings

The average analyst rating for Harvard Bioscience stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy000000
Buy222221
Hold111110
Sell000000
Strong Sell000000
Total333331

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Benchmark
Benchmark
Buy
Maintains
$0.6$6
BuyMaintains$0.6$6+7.33%Mar 16, 2026
Benchmark
Benchmark
Buy
Maintains
$2$0.6
BuyMaintains$2$0.6-89.27%Mar 13, 2026
Benchmark
Benchmark
Buy
Maintains
$30$20
BuyMaintains$30$20+257.78%Sep 10, 2025
Benchmark
Benchmark
Buy
Maintains
$45$30
BuyMaintains$45$30+436.67%May 13, 2025
Keybanc
Keybanc
Hold
Downgrades
n/a
HoldDowngradesn/an/aApr 9, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
90.37M
from 86.55M
Increased by 4.42%
Revenue Next Year
96.08M
from 90.37M
Increased by 6.32%
EPS This Year
-1.59
from -12.80
EPS Next Year
0.45
from -1.59
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
118.90M113.34M112.25M94.14M86.55M90.37M96.08M
Revenue Growth
16.46%-4.68%-0.96%-16.14%-8.06%4.42%6.32%
EPS
-0.10-2.30-0.81-2.85-12.80-1.590.45
EPS Growth
-------
Forward PE
------12.46
No. Analysts
-----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027
High93.2M100.8M
Avg90.4M96.1M
Low86.6M90.6M

Revenue Growth

Revenue Growth20262027
High
7.7%
11.5%
Avg
4.4%
6.3%
Low
0.1%
0.2%

EPS Forecast

EPS20262027
High-0.180.61
Avg-1.590.45
Low-2.880.29

EPS Growth

EPS Growth20262027
High--
Avg--
Low--
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.